3
Conclusion
In summary, we have shown that 2-methoxy-2E, 4-hexa
dienonate derivatives are effective substrate type for the facile
reductive oxy-Nazarov cyclization. This cyclopentenone
annulation represents
a new variant of the iso-Nazarov
cyclization.5 Some typical examples of iso-Nazarov cyclization
of pentadienals leading to substituted cyclopentenones are
illustrated in Figure 3.
Figure 3 Typical examples of iso-Nazarov of pentadienals.
Further studies on the scope and application of this facile
transformation in natural product synthesis will be reported in
due course.
Scheme 4 RON cyclization of 17.
To our delight, the Dibal-H reduction of the isomeric
precursor 17, which was prepared analogously from the aldehyde
15 via the HWE olefination reaction as shown in Scheme 4,
produced the cyclopentenone 19 in 26% yield along with 42%
yield of alcohol product 18, which was oxidized with IBX in
DMSO effectively to give 19 in 56% yield (Scheme 4). The
relative stereochemistry of compound 19 was further confirmed
by X-ray crystallographic analysis.7 Cyclopentenone product 19
serves as a key intermediate in the cephalotaxine total synthesis.8
Other 3-substituted 2-methoxy-2, 4-hexadienoates such as 20
can be cyclized by the action of Dibal-H to give cyclopentenone
22 less effectively (Scheme 5a). Intriguingly, it seems that proton
chelate species of type b intermediate (Figure 2b) of the
corresponding aldehyde of 21 underwent smooth oxy-Nazarov
cyclization (22 21). In contrast, 3-methyl substituted
dioxalanone analog of type I, such as 23, undergo oxy-Nazarov
cyclization in moderate yield (Scheme 5b). The above results
imply that the reactivity of this novel variant of iso-Nazarov
cyclization depends largely on the olefinic geometry and the
nature of substituents which deserves further systematic study.
Acknowledgments
We are grateful to Mr. Ning-Dong Zhao for partial
experimental work. We thank the National Natural Science
Foundation (21132006) for financial support. The scholars
program of Chongqing University is gratefully acknowledged.
Supplementary Material
Supplementary data associated with this article can be found,
in the online version, at
(web link).
References and notes
1. Li, W. D. Z.; Duo, W. G.; Zhuang, C. H. Org. Lett. 2011, 13, 3538-3541.
2. For recent reviews, see: a) Frontier, A. J.; Collison, C. Tetrahedron
2005, 61, 7577-7606; b) Pellissier, H. Tetrahedron 2005, 61, 6479-6517;
c) Tius, M. A. Eur. J. Org. Chem. 2005, 2193-2206; d) Shimada, N.;
Stewart, C.; Tius, M. A. Tetrahedron 2011, 67, 5851-5870; e) Vaidya, T.;
Eisenberg, R.; Frontier, A. J. Chemcatchem 2011, 3, 1531-1548; f)
Audran, G.; Brémond, P.; Feuerstein, M.; Marque, S. R. A.; Santelli, M.
Tetrahedron 2013, 69, 8325-8348; g) Brooks, J. L.; Huang, Y. W.;
Frontier, A. J. Org. Synth. 2014, 91, 93-105; h) Di Grandi, M. J. Org.
Biomol. Chem. 2014, 12, 5331-5345; i) Tius, M. A. Chem. Soc. Rev.
2014, 43, 2979-3002.
3. For preparation of 1, see: Chowdari, N. S.; Barbas, C. F., III. Org. Lett.
2005, 7, 867-870.
4. For preparation of 2, see: Seneci, P.; Leger, I.; Souchet, M.; Nadler, G.
Tetrahedron 1997, 53, 17097-17114.
5. For selected examples of the iso-Nazarov, see: a) Miller, A. K.;
Banghart, M. R.; Beaudry, C. M.; Suh, J. M.; Trauner, D. Tetrahedron
2003, 59, 8919-8930; b) Yoshimatsu, M.; Matsuura, Y.; Gotoh, K.
Chem. Pharm. Bull. 2003, 51, 1405-1412; c) Kuroda, C.; Honda, S.;
Nagura, Y.; Koshio, H.; Shibue, T.; Takeshita, T. Tetrahedron 2004, 60,
319-331; (d) Jung, M. E.; Yoo, D. J. Org. Chem. 2007, 72, 8565-8568;
e) Riveira, M. J.; Mischne, M. P. J. Org. Chem. 2014, 79, 8244-8254
6. For method of preparation of 9 and 10, see: Maddess, M. L.; Tackett, M.
N.; Watanabe, H.; Brennan, P. E.; Spilling, C. D.; Scott, J. S.; Osborn,
Scheme 5 RON cyclization of 20 and 23.